🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see if administration of medicines and gene...
Status
Completed
Location
Indiana University
Start Date
2010-03
Trial ID
NCT01104376
Treatments Being Tested
The purpose of the study is to screen the optimal intervention strategies t...
Status
Unknown
Location
Lincang Center for Disease Control and Prevention
Start Date
2019-03-01
Trial ID
NCT03852849
Treatments Being Tested
Clinical data suggests that the standard dose of the anti-HIV medication, e...
Status
Completed
Location
St Vincent's Hospital
Start Date
2011-08
Trial ID
NCT01011413
Treatments Being Tested
Phase III trial evaluating raltegravir as an alternative to efavirenz for a...
Status
Completed
Location
Laboratory of clinical research on STD/AIDS - IPEC/FIOCRUZ
Start Date
2015-09-11
Trial ID
NCT02273765
Treatments Being Tested
The purpose is to investigate whether HIV and HIV medication can affect cer...
Status
Completed
Location
HIVNAT Research Collaboration
Start Date
2012-01
Trial ID
NCT01516060
Persistent HIV infection in the central nervous system (CNS) compartment ma...
Status
Completed
Location
Medical Group Practice
Start Date
2011-09
Trial ID
NCT01451333
Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (4...
Status
Completed
Location
E-Da Hospital
Start Date
2018-12-06
Trial ID
NCT03595709
Treatments Being Tested
IMPAACT P1026s is a Phase IV prospective clinical study to evaluate the pha...
Status
Completed
Location
UAB Pediatric Infectious Diseases CRS
Start Date
2003-06-09
Trial ID
NCT00042289
Treatments Being Tested
This study is a two-arm prospective 1:1 randomised controlled trial compari...
Status
Completed
Location
SEARCH, the Thai Red Cross AIDS Research Centre
Start Date
2015-01
Trial ID
NCT02475915
Treatments Being Tested